Limitations of the PRODIGE 7 trial
Lancet Oncol
.
2021 May;22(5):e176.
doi: 10.1016/S1470-2045(21)00088-7.
Authors
Fabio Carboni
1
,
Mario Valle
2
Affiliations
1
Peritoneal Tumours Unit, IRCCS Regina Elena National Cancer Institute, Rome 00144, Italy. Electronic address: fabiocarb@tiscali.it.
2
Peritoneal Tumours Unit, IRCCS Regina Elena National Cancer Institute, Rome 00144, Italy.
PMID:
33932374
DOI:
10.1016/S1470-2045(21)00088-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Colorectal Neoplasms* / drug therapy
Cytoreduction Surgical Procedures
Humans
Hyperthermic Intraperitoneal Chemotherapy
Leucovorin / therapeutic use
Peritoneal Neoplasms*
Substances
Leucovorin